Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Theravance, Inc.”

369 pharma patents match "Theravance, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 369
Index total 30,257
Page 5 / 16

Quick answer

This filtered view shows 369 pharmaceutical patents matching "Theravance, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

369 results for “Theravance, Inc.” · 30,257 patents in full index Clear search

  1. US 8188294

    Process for preparing biphenyl imidazole compounds

    Theravance, Inc. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  2. US 8173815

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted May 8, 2012 · Expires May 3, 2032

    granted
  3. US 8163920

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  4. US 8163794

    Crystalline form of a 3-phenoxymethylpyrrolidine compound

    Theravance, Inc. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  5. US 8158659

    Dual-acting imidazole antihypertensive agents

    Theravance, Inc. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted
  6. US 8158580

    Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

    Theravance, Inc. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted
  7. US 8153675

    Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Theravance, Inc. · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted
  8. US 8153686

    Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted
  9. US 8143277

    Method of using compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  10. US 8143298

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  11. US 8143279

    Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  12. US 8138345

    Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

    Theravance, Inc. · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  13. US 8133905

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  14. US 8134006

    Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  15. US 8124627

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted
  16. US 8119796

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  17. US 8119634

    Dual-acting pyrazole antihypertensive agents

    Theravance, Inc. · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  18. US 8106232

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  19. US 8106082

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  20. US 8101791

    Aminotetralin compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  21. US 8101575

    Glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  22. US 8101794

    Crystalline forms of a 3-carboxypropyl-aminotetralin compound

    Theravance, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  23. US 8101766

    Crystalline form of a biphenyl compound

    Theravance, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  24. US 8093354

    Process for preparing glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted